Kelty E - Search Results

1

Morbidity and mortality in opioid dependent patients after entering an opioid pharmacotherapy compared with a cohort of non-dependent controls.

Kelty E, Hulse G. Kelty E, et al. J Public Health (Oxf). 2018 Jun 1;40(2):409-414. doi: 10.1093/pubmed/fdx063. J Public Health (Oxf). 2018. PMID: 28591852

2

Examination of mortality rates in a retrospective cohort of patients treated with oral or implant naltrexone for problematic opiate use.

Kelty E, Hulse G. Kelty E, et al. Addiction. 2012 Oct;107(10):1817-24. doi: 10.1111/j.1360-0443.2012.03910.x. Epub 2012 May 17. Addiction. 2012. PMID: 22487087

3

Assessing the usefulness of health data linkage in obtaining adverse event data in a randomised controlled trial of oral and implant naltrexone in the treatment of heroin dependence.

Kelty E, Ngo H, Hulse G. Kelty E, et al. Clin Trials. 2013 Feb;10(1):170-80. doi: 10.1177/1740774512467237. Epub 2012 Dec 14. Clin Trials. 2013. PMID: 23241479 Clinical Trial.

4

A retrospective assessment of the use of naltrexone implants for the treatment of problematic amphetamine use.

Kelty E, Thomson K, Carlstein S, Sinclair R, Hulse G. Kelty E, et al. Am J Addict. 2013 Jan;22(1):1-6. doi: 10.1111/j.1521-0391.2013.00320.x. Am J Addict. 2013. PMID: 23398219

5

Use of subcutaneous flumazenil preparations for the treatment of idiopathic hypersomnia: A case report.

Kelty E, Martyn V, O'Neil G, Hulse G. Kelty E, et al. J Psychopharmacol. 2014 Jul;28(7):703-6. doi: 10.1177/0269881114523865. Epub 2014 Feb 19. J Psychopharmacol. 2014. PMID: 24554692

6

Changes in hospital and out-patient events and costs following implant naltrexone treatment for problematic alcohol use.

Kelty E, Hayes L, O'Neil G, Kyle S, Jeffrey GP, O'Neil G, Hendrie D, Mukhtar A, Hulse G. Kelty E, et al. J Psychopharmacol. 2014 Aug;28(8):745-50. doi: 10.1177/0269881114536791. Epub 2014 Jun 5. J Psychopharmacol. 2014. PMID: 24902873

7

Cis-Expression Quantitative Trait Loci Mapping Reveals Replicable Associations with Heroin Addiction in OPRM1.

Hancock DB, Levy JL, Gaddis NC, Glasheen C, Saccone NL, Page GP, Hulse GK, Wildenauer D, Kelty EA, Schwab SG, Degenhardt L, Martin NG, Montgomery GW, Attia J, Holliday EG, McEvoy M, Scott RJ, Bierut LJ, Nelson EC, Kral AH, Johnson EO. Hancock DB, et al. Biol Psychiatry. 2015 Oct 1;78(7):474-84. doi: 10.1016/j.biopsych.2015.01.003. Epub 2015 Jan 29. Biol Psychiatry. 2015. PMID: 25744370 Free PMC article.

8

Novel Indications for Benzodiazepine Antagonist Flumazenil in GABA Mediated Pathological Conditions of the Central Nervous System.

Hulse G, Kelty E, Hood S, Norman A, Basso MR, Reece AS. Hulse G, et al. Among authors: kelty e. Curr Pharm Des. 2015;21(23):3325-42. doi: 10.2174/1381612821666150619092720. Curr Pharm Des. 2015. PMID: 26088116 Review.

9

Emergency department based intervention with adolescent substance users: 10year economic and health outcomes.

Tait RJ, Teoh L, Kelty E, Geelhoed E, Mountain D, Hulse GK. Tait RJ, et al. Among authors: kelty e. Drug Alcohol Depend. 2016 Aug 1;165:168-74. doi: 10.1016/j.drugalcdep.2016.06.005. Epub 2016 Jun 11. Drug Alcohol Depend. 2016. PMID: 27317044 Clinical Trial.

10

Erratum to "Emergency department based intervention with adolescent substance users: 10year economic and health outcomes" [Drug Alcohol Depend. 165 (2016) 168-174].

Tait RJ, Teoh L, Kelty E, Geelhoed E, Mountain D, Hulse GK. Tait RJ, et al. Among authors: kelty e. Drug Alcohol Depend. 2016 Oct 1;167:236. doi: 10.1016/j.drugalcdep.2016.08.005. Epub 2016 Aug 8. Drug Alcohol Depend. 2016. PMID: 27515724 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

91 results

Search Page

Filters